FR2346003A1 - 9-Oxo-11-alpha methyl prosta-13-enoic acid derivs - as selective anti-ulcer agents without hypotensive or intestinal-contracting side effects - Google Patents

9-Oxo-11-alpha methyl prosta-13-enoic acid derivs - as selective anti-ulcer agents without hypotensive or intestinal-contracting side effects

Info

Publication number
FR2346003A1
FR2346003A1 FR7516321A FR7516321A FR2346003A1 FR 2346003 A1 FR2346003 A1 FR 2346003A1 FR 7516321 A FR7516321 A FR 7516321A FR 7516321 A FR7516321 A FR 7516321A FR 2346003 A1 FR2346003 A1 FR 2346003A1
Authority
FR
France
Prior art keywords
oxo
hypotensive
intestinal
side effects
enoic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7516321A
Other languages
French (fr)
Other versions
FR2346003B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Priority to FR7516321A priority Critical patent/FR2346003A1/en
Publication of FR2346003A1 publication Critical patent/FR2346003A1/en
Application granted granted Critical
Publication of FR2346003B1 publication Critical patent/FR2346003B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Prostenoic acid derivs. of formula (I) and their pharmaceutically acceptable salts are new: (where A = 4-8 C alkylene, esp. hexamethylene; R1 = 1-5C alkyl, esp. n-propyl; R2 and R3 are H or 1-4 C alkyl; R4 = H or 1-4 C alkyl). They are prepd. from corresp. 9-(protected oxo)-15-oxo cpd. by redn. then deprotection. (I) are anti-ulcer agents with little or no hypotensive or intestinal-contracting side effects. Thus, in the rat, 9-oxo-11 alpha 16, 16-trimethyl-15 alpha-hydroxyprost-13-trans-enoic acid has ED50 against indomethacin-(30 mg./kg.) induced ulcer of 0.16 mg./kg. Usual dose is 0.5-100 mg./day for adults e.g., as 3-4 tablets.
FR7516321A 1975-05-26 1975-05-26 9-Oxo-11-alpha methyl prosta-13-enoic acid derivs - as selective anti-ulcer agents without hypotensive or intestinal-contracting side effects Granted FR2346003A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7516321A FR2346003A1 (en) 1975-05-26 1975-05-26 9-Oxo-11-alpha methyl prosta-13-enoic acid derivs - as selective anti-ulcer agents without hypotensive or intestinal-contracting side effects

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7516321A FR2346003A1 (en) 1975-05-26 1975-05-26 9-Oxo-11-alpha methyl prosta-13-enoic acid derivs - as selective anti-ulcer agents without hypotensive or intestinal-contracting side effects

Publications (2)

Publication Number Publication Date
FR2346003A1 true FR2346003A1 (en) 1977-10-28
FR2346003B1 FR2346003B1 (en) 1978-11-03

Family

ID=9155666

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7516321A Granted FR2346003A1 (en) 1975-05-26 1975-05-26 9-Oxo-11-alpha methyl prosta-13-enoic acid derivs - as selective anti-ulcer agents without hypotensive or intestinal-contracting side effects

Country Status (1)

Country Link
FR (1) FR2346003A1 (en)

Also Published As

Publication number Publication date
FR2346003B1 (en) 1978-11-03

Similar Documents

Publication Publication Date Title
UA8022A1 (en) Process for the preparation of benzimidazole derivatives as isomeric mixture or individual isomers in free state , or as pharmaceutically acceptable salts thereof
ZA919181B (en) Oxazolopyridine derivatives,processes for preparing these and pharmaceutical compositions containing them
YU86483A (en) Process for obtaining ethanolamine derivatives
MY100095A (en) 2-oxo-imidazolidine compounds, a process for preparing the same and a pharmaceutical composition.
ZA904495B (en) Peptide derivatives,process for preparing them and pharmaceutical compositions containing them
ES8404360A1 (en) 7-Acylamino-3-cephem-4-carboxylic acid derivatives, processes for the preparation of the same and pharmaceutical composition comprising the same.
IE38979L (en) Tetrazolyl - quinoxalinecarboxamide derivatives
NL7506255A (en) 9-Oxo-11-alpha methyl prosta-13-enoic acid derivs - as selective anti-ulcer agents without hypotensive or intestinal-contracting side effects
FR2346003A1 (en) 9-Oxo-11-alpha methyl prosta-13-enoic acid derivs - as selective anti-ulcer agents without hypotensive or intestinal-contracting side effects
WO1990003172A3 (en) Bile acids for treatment of viral infections
ES447495A1 (en) 4,5,6,7-Tetrahydro-thieno{8 3,2-c{9 -pyridine derivatives and process for their preparation
JPS52278A (en) Process for preparing piperidylbenzimidazole derivatives
ES2032838T3 (en) A PROCEDURE FOR PREPARING TETRAHYDROPIRIDE DERIVATIVES (1,2-A) INDOL.
ES8702392A1 (en) Thiadiazinone compounds, process for their preparation, and pharmaceutical compositions containing them.
JPS5233682A (en) Preparation of 1,3-bis(2'-tetrahydrofuryl)-5-flurouracil
ES476124A1 (en) Amino acid derivatives, process for obtaining them, intermediate compounds in obtaining them and pharmaceutical compositions containing them.
JPS5212171A (en) Process for preparation of cyclohexane derivatives
JPS52139094A (en) 1-fluoralkyl-1,4-dihydro-4-oxo-3-pyridinecarboxylic acid derivatives
JPS52136165A (en) Purification of pyrrolidine derivatives
JPS51141880A (en) Process for preparing carbostyril derivatives
JPS525782A (en) Preparation of 1-phthalazinone
JPS5219647A (en) Preparation of 3-aminomethyl-4- homoisotwistane and its acid addition salt
JPS51136682A (en) Process for preparing 5-alkanoylcarbostyril derivatives.
JPS51128974A (en) Process for producing piperidylbenzimidazole derivatives
JPS5430163A (en) 2-aminomethyl-5-phenyloxazoles and their pharmaceutically acceptable acid salts

Legal Events

Date Code Title Description
ST Notification of lapse